for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Gritstone bio Inc

GRTS.O

Latest Trade

4.95USD

Change

0.21(+4.43%)

Volume

1,228,718

Today's Range

4.62

 - 

4.97

52 Week Range

4.59

 - 

22.04

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
4.74
Open
4.78
Volume
1,228,718
3M AVG Volume
41.71
Today's High
4.97
Today's Low
4.62
52 Week High
22.04
52 Week Low
4.59
Shares Out (MIL)
67.99
Market Cap (MIL)
343.34
Forward P/E
-4.55
Dividend (Yield %)
--

Next Event

Q4 2021 Gritstone bio Inc Earnings Release

Latest Developments

More

Gritstone Announces Positive Clinical Results from First Cohort of a Phase 1 Study Evaluating a T Cell-Enhanced Self-Amplifying mRNA Vaccine Against COVID-19

Gritstone bio and CEPI Expand Vaccine Agreement to Tackle Omicron Variant

Gritstone Reports Third Quarter 2021 Financial Results

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Gritstone bio Inc

Gritstone bio, Inc., formerly Gritstone Oncology, Inc., is a biotechnology company. The Company is focused on developing targeted immunotherapies for cancer and infectious disease. The Company's programs are built on two key pillars: Gritstone EDGE artificial intelligence platform, which enables the Company to identify antigens that can be recognized by the immune system; and a potent immunotherapy platform, which is engineered to deliver the selected antigens. Its pipeline include GRANITE, SLATE, BiSAb and CORAL. GRANITE is the Company's first oncology product candidate, which is a personalized neoantigen-based immunotherapy. SLATE utilizes the same neoantigen delivery system as GRANITE but contains a fixed set of neoantigens that are shared across a subset of cancer patients. The Company has a program focused on the development of bispecific antibody (BiSAb) therapeutics using highly tumor-specific antigens. CORAL is a second-generation vaccine against SARS-CoV-2.

Industry

Biotechnology & Drugs

Contact Info

5959 HORTON STREET, SUITE 300

EMERYVILLE, CA

94608

United States

+1.510.8716100

https://gritstonebio.com/

Executive Leadership

Elaine V. Jones

Chairman of the Board

Andrew R. Allen

President, Chief Executive Officer, Director

Vassiliki Celia Economides

Chief Financial Officer, Executive Vice President

Erin Jones

Chief Operating Officer

Rahsaan Thompson

Executive Vice President, General Counsel

Key Stats

2.00 mean rating - 4 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

0.0K

2019

0.0K

2020

0.0K

2021(E)

0.0K
EPS (USD)

2018

-7.260

2019

-2.810

2020

-2.790

2021(E)

-1.043
Price To Earnings (TTM)
--
Price To Sales (TTM)
7.38
Price To Book (MRQ)
1.56
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
-43.21
Return on Equity (TTM)
-36.81

Latest News

Latest News

Gritstone secures funding for COVID-19 vaccine against variants

Gritstone bio Inc said on Tuesday it had entered into a funding agreement of up to $20.6 million with the Coalition for Epidemic Preparedness Innovations (CEPI) to advance its vaccine program against COVID-19 variants, sending its shares up 2.6% before the bell.

Gritstone in funding deal with CEPI for COVID-19 vaccine against variants

Gritstone bio Inc said on Tuesday it had entered into a funding agreement of up to $20.6 million with the Coalition for Epidemic Preparedness Innovations (CEPI) to advance its COVID-19 vaccine program against coronavirus variants. (Reporting by Dania Nadeem in Bengaluru)

BRIEF-Gritstone Oncology Appoints Rahsaan Thompson As General Counsel

* GRITSTONE ONCOLOGY ANNOUNCES THE APPOINTMENT OF VETERAN LEGAL EXECUTIVE RAHSAAN THOMPSON AS GENERAL COUNSEL Source text for Eikon: Further company coverage:

BRIEF-Gritstone Oncology Reports Qtrly Loss Per Share $0.77

* GRITSTONE ONCOLOGY REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND RECENT HIGHLIGHTS

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up